(Q28171145)

12 December 2020

Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics

1 reference

12 December 2020

The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions

1 reference

12 December 2020

Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells

1 reference

12 December 2020

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

1 reference

12 December 2020

Bronchoprotective role for endogenous prostaglandin E2

1 reference

12 December 2020

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

1 reference

12 December 2020

The cyclooxygenase theory of aspirin-induced asthma.

1 reference

12 December 2020

Inhaled corticosteroids (budesonide): the cornerstone of asthma therapy--what are the options?

1 reference

12 December 2020

Choline magnesium trisalicylate in patients with aspirin-induced asthma

1 reference

12 December 2020

The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.

1 reference

12 December 2020

Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma

1 reference

12 December 2020

Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients

1 reference

12 December 2020

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

1 reference

12 December 2020

Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide (SO)2-induced bronchoconstriction

1 reference

12 December 2020

Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells

1 reference

12 December 2020

Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma

1 reference

12 December 2020

Inhibition of monocyte leukotriene B production after aspirin desensitization

1 reference

12 December 2020

Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics

1 reference

12 December 2020

Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics

1 reference

12 December 2020

Development and clinical application of COX-2-selective inhibitors for the treatment of osteoarthritis and rheumatoid arthritis

1 reference

12 December 2020

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

1 reference

12 December 2020

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

12 December 2020

Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.

1 reference

12 December 2020

Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078

1 reference

12 December 2020

Antileukotrienes in asthma: present situation

1 reference

12 December 2020

The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma

1 reference

12 December 2020

1 reference

12 December 2020

Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma

1 reference

12 December 2020

Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients

1 reference

12 December 2020

Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma

1 reference

12 December 2020

Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance.

1 reference

12 December 2020

Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry

1 reference

12 December 2020

Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma

1 reference

12 December 2020

The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients

1 reference

12 December 2020

Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes

1 reference

12 December 2020

Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma

1 reference

12 December 2020

Regulation of the Immune Response by Eicosanoids: Pharmacology and Clinical Effects of Prostaglandin E in Aspirin-Sensitive Syndromes

1 reference

12 December 2020

Serum interleukin-5 in aspirin-induced asthma

1 reference

12 December 2020

Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin-sensitive asthmatics

1 reference

12 December 2020

Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid

1 reference

12 December 2020

Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients

1 reference

12 December 2020

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

12 December 2020

T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma

1 reference

12 December 2020

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients

1 reference

12 December 2020

Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma

1 reference

12 December 2020

Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA)

1 reference

12 December 2020

Effect of indomethacin on adenosine-induced bronchoconstriction

1 reference

12 December 2020

Acute Churg-Strauss syndrome in an asthmatic patient receiving montelukast therapy

1 reference

12 December 2020

A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma

1 reference

12 December 2020

The importance of COX-2 inhibition for aspirin induced asthma

1 reference

12 December 2020

Churg-Strauss syndrome in two patients receiving montelukast

1 reference

12 December 2020

Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release

1 reference

12 December 2020

COX-3: just another COX or the solitary elusive target of paracetamol?

1 reference

12 December 2020

The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.

1 reference

12 December 2020

Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism

1 reference

12 December 2020

Effects of a cyclo-oxygenase inhibitor, flurbiprofen, and an H1 histamine receptor antagonist, terfenadine, alone and in combination on allergen induced immediate bronchoconstriction in man.

1 reference

12 December 2020

Leukotrienes as mediators of airway obstruction and inflammation in asthma

1 reference

12 December 2020

Safety of a specific COX-2 inhibitor in aspirin-induced asthma

1 reference

12 December 2020

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

1 reference

12 December 2020

Proposed mechanisms of aspirin sensitivity reactions

1 reference

12 December 2020

Indomethacin modification of immediate-type immunologic airway responses in allergic asthmatic and non-asthmatic subjects: evidence for altered arachidonic acid metabolism in asthma

1 reference

12 December 2020

Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type

1 reference

12 December 2020

The safety of celecoxib in patients with aspirin-sensitive asthma

1 reference

12 December 2020

The COX-1/COX-2 balance in asthma

1 reference

12 December 2020

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients

1 reference

12 December 2020

Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

The effect of oral terfenadine alone and in combination with flurbiprofen on the bronchoconstrictor response to inhaled adenosine 5'-monophosphate in nonatopic asthma

1 reference

12 December 2020

Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma

1 reference

12 December 2020

Viral infection induces dependence of neuronal M2 muscarinic receptors on cyclooxygenase in guinea pig lung.

1 reference

12 December 2020

Leukotriene antagonists and the Churg-Strauss syndrome.

1 reference

12 December 2020

Interactions between prostaglandins and leukotrienes

1 reference

12 December 2020

Uncoupled regulation of leukotriene C4 synthase in platelets from aspirin-intolerant asthmatics and healthy volunteers after aspirin treatment

1 reference

12 December 2020

Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast

1 reference

12 December 2020

Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions

1 reference

12 December 2020

Too many COX (cyclo-oxygenase) spoil the broth: aspirin-sensitive asthma and 5-lypoxygenase

1 reference

12 December 2020

Genetics of aspirin induced asthma

1 reference

12 December 2020

Inhibition of sodium metabisulphite induced bronchoconstriction by frusemide in asthma: role of cyclooxygenase products

1 reference

12 December 2020

The Churg-Strauss syndrome after pranlukast treatment in a patient not receiving corticosteroids

1 reference

12 December 2020

Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma

1 reference

12 December 2020

Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics

1 reference

12 December 2020

Churg-Strauss syndrome (CSS) in a patient receiving pranlukast

1 reference

12 December 2020

Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma

1 reference

12 December 2020

Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism

1 reference

12 December 2020

Analgesics and asthma

1 reference

12 December 2020

Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma

1 reference

12 December 2020

Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution

1 reference

12 December 2020

Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease

1 reference

12 December 2020

The natural history and clinical characteristics of aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma

1 reference

12 December 2020

Paracetamol and asthma

1 reference

12 December 2020

Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease

1 reference

12 December 2020

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma

1 reference

12 December 2020

Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day

1 reference

12 December 2020

Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis

1 reference

12 December 2020

Aspirin-sensitive asthma due to diffuse neuroendocrine system pathology

1 reference

12 December 2020

Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics

1 reference

12 December 2020

Tolerability of Asacard--controlled-release aspirin and aspirin-induced asthma

1 reference

12 December 2020

Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects

1 reference

12 December 2020

Autoimmune vasculitis and aortic stenosis in aspirin-induced asthma (AIA)

1 reference

12 December 2020

Molecular cloning of the gene for human leukotriene C4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35

1 reference

12 December 2020

Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma

1 reference

12 December 2020

The role of antileukotrienes in the treatment of asthma.

1 reference

12 December 2020

Aspirin-sensitive versus non-aspirin-sensitive nasal polyp patients: analysis of leukotrienes/Fas and Fas-ligand expression

1 reference

12 December 2020

A comparative study in atopic subjects with asthma of the effects of salmeterol and salbutamol on allergen-induced bronchoconstriction, increase in airway reactivity, and increase in urinary leukotriene E4 excretion

1 reference

12 December 2020

Polyisoprenyl phosphates: natural antiinflammatory lipid signals

1 reference

12 December 2020

Bronchial response to nonsteroidal anti-inflammatory drugs in asthmatic patients.

1 reference

12 December 2020

Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha

1 reference

12 December 2020

Possible relevance of virus infection for development of analgesic idiosyncrasy

1 reference

12 December 2020

Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction

1 reference

12 December 2020

Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes

1 reference

12 December 2020

A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge

1 reference

12 December 2020

Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma

1 reference

12 December 2020

Epifamine efficacy in aspirin bronchial asthma

1 reference

12 December 2020

Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.

1 reference

12 December 2020

Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics

1 reference

12 December 2020

COX-2 expression in asthmatic airways: the story so far.

1 reference

12 December 2020

Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics

1 reference

12 December 2020

Aspirin-induced asthma as a viral disease

1 reference

12 December 2020

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

1 reference

12 December 2020